Table 1.
Organ | Preclinical Model | Treatment | Outcome | Mechanism | References |
---|---|---|---|---|---|
Heart | Anthracycline-induced cardiomyopathy in mice | iPSC-MSCs and BM-MSCs | iPSC-MSC preserved heart tissue better than BM-MSCs. | Efficiency of Mt transfer TNT formation MSC expression of Miro1 |
Zhang et al., 2016 [158] |
Doxorubicin-induced injury in human cardiomyocytes in vitro |
Co-culture or direct contact with MSC-EVs | Large MSC-EVs (>200 nm) ameliorated cardiomyocyte injury. Inhibition of Mt function in MSC-EVs attenuated efficacy. |
Improved contractility ↑ ATP production ↑ Mt biogenesis |
O’Brien et al., 2021 [163] | |
Cardiomyocytes (H9c2) IRI in vitro |
MSC-H9c2 co-culture | Marked resistance against IRI | ↓ apoptosis ↑ Mt transfer from MSC to H9c2 via TNT formation |
Han et al., 2016 [164] | |
MI in mice | MSC-Mt transplanted in peri-infarct area | MSC-Mt preserved better cardiac function after MI then fibroblast derived Mt. | ↑ Vessel density in MI area ↓ Apoptosis and endothelial cell senescence (via ERK pathway activation) ↓ Heart remodeling |
Liang et al., 2023 [165] | |
Co-culture of MSCs and cardiomyocytes or endothelial cells pretreated with H2O2. MI in mice |
MSCs | Increased capacity of injured cells to combat oxidative stress. Reduced damage of infarcted mouse hearts. |
Mitochondrial exchange between MSCs and damaged cells ↑ HO-1 ↑ mitochondrial biogenesis |
Mahrouf-Yorgov et al., 2017 [150] | |
Hibernating myocardium model without infarction in juvenile swine (surgical stenosis of the left anterior desc. coronary artery) | Epicardial MSC patch applied during coronary artery bypass graft | Improved myocardial function (measured by cardiac magnetic resonance imaging). Improved Mt function. |
Improved Mt morphology ↑ Mt biogenesis and ATP production in cardiac tissue |
Hocum et al., 2021 [166] | |
MI in mice | MSCs preconditioned or not with Mt | MSCs primed with Mt had increased capacity to repair mouse myocardial infarct. | ↑ Mitophagy of exogenous Mt ↑ Anti-inflammatory, proangiogenic and anti-fibrotic properties of MSCs primed with Mt. |
Vignais et al., 2023 [167] | |
Lung | MSC/alveolar Mϕ direct co-culture | BM-MSCs | ↑ Mϕ oxidative phosphorylation and phagocytosis | Mt transfer from MSCs to Mϕ by TNT formation | Jackson et al., 2017 [171] |
E. coli mouse ARDS model | BM-MSCs | ↑ Mϕ phagocytosis Antibacterial effect |
Mt from MSC aquired by lung Mϕ through TNT formation ↑ Phagocytic activity of Mϕ positive for MSC Mt |
Jackson et al., 2016 [147] | |
Mϕ and MSC non-contact co-culture stimulated with LPS or BALF from ARDS patients ARDS mouse model |
MSCs Alveolar Mϕ cultured with and without MSC-EVs |
↓ Cytokine production ↑ M2-like Mϕ marker expression ↓ Pulmonary inflammation ↓ Lung injury |
↑ Mϕ phagocytic capacity Involvement of Mt in Mϕ & CD44 in MSC-EVs Crucial role of Mt in Mϕs and MSC-EVs |
Morrison et al., 2017 [160] | |
Primary cells and human lung cuts exposed to endotoxin or plasma of ARDS patients (in vitro) ARDS mouse LPS model |
MSC-EVs | Improvement of increased cell permeability and Mt dysfunction ↓ Lung injury Restoration of alveolar-capillary barrier |
Normalization of oxidative phosphorylation EVs with dysfunctional Mt was ineffective. Mt transfer and restoration of Mt function |
Dutra–Silva et al., 2021 [172] | |
Acute lung IRI rat model Lung epithelial cell line exposed to H/R injury (in vitro) |
AD-MSCs and iPSC-MSCs | Similar lung protection with both AD-MSCs and iPSC-MSCs ↓ Lung injury score ↓ Inflammation cells |
↓ Mitochondrial damage/cell apoptosis, autophagy, and oxidative stress ↓ Drp-1, Mt Bax/caspase3/8/9 and authophagy pathways (in vitro) |
Lin et al., 2020 [173] | |
ASMCs exposed to cigarette smoke media COPD mouse model (exposure to ozon) |
iPSC-MSCs | ↓ Mt ROS ↓ Airway inflammation and hyperresponsiveness |
Mt transfer to donor cells ↑ Mt function |
Li et al., 2018 [175] | |
COPD mouse model (mice exposed to cigarette smoke for 10 days) BEAS2B-mMSC co-cultures |
MSCs, MSC-EVs, MSC + MSC-EVs |
↓ Bronchial epithelial damage ↓ Inflammatory cellular infiltration |
↑ Mitofusin 1 and 2 ↑ Mt transfer ↓ Pro-inflammatory cytokines Same changes confirmed in co-culture settings |
Maremanda et al., 2019 [176] | |
Asthma mouse model | MSCs (naïve, over-expressing or knockout for Miro-1) |
↓ Allergic inflammation and hyperresponsiveness of airways ↓ Lung injury |
Mt transfer from MSCs to bronchial epithelial cells; Rho-GTPase Miro1-dependent process | Ahmad et al., 2014 [156] | |
Asthma mouse model | BM-MSCs | ↓ Lung inflammation ↓ Goblet cells mucus hyper-production Improved lung morphology |
↓ Eosinophils and allergo-inflammatory cytokines ↓ Asthma induced mitochondrial gene expression ↑ Mt function |
Huang et al., 2021 [177] | |
Asthma mouse model | MSCs preconditioned or not with serum of asthma patients | ↓ Lung inflammation ↓ Lung fibrosis ↑ Lung tissue regeneration |
↑ Expression of TGFβ, IDO-1, TSG-6 by hMSC-serum ↑ fission ↓ respiratory capacity of Mt ↑ MSC apoptosis and their phagocytosis by Mϕ ↑ M2 Mϕ polarization |
Abreu at al., 2023 [178] | |
Co-culture of alveolar Mϕ and MSCs or MSC-EVs (in vitro) Mouse severe emphysema model |
MSCs or MSC-EVs from healthy (H) and emphysematous (E) donor mice | Immunomodulatory effects ↑ IL-10 Improvement of cardiorespiratory dysfunction with MSC-EVs only from H donors |
Abnormal Mt in E-MSCs and E-EVs—elongated, less functional and produced ↑ ROS vs. Mt from H-MSCs and H-EVs H-EVs showed better efficacy in comparison with H-MSCs, since they could access smaller airways, unreachable for MSCs. |
Antunes et al., 2021 [179] | |
ELBW infants with/without BPD (n = 39) UC-MSCs taken and studied in vitro |
Endogenous MSCs isolated | MSCs with: Mt dysfuction ↓ ATP production and mytophagy ↓ Mt survival associated with BPD risk in ELBW infants. |
Mt abnormalities may cause endogenous MSC pool depletion and disruptions in ELBW infant lungs. | Hazra et al., 2022 [180] | |
IPF patients IPF (bleomycin) mouse model |
Endogenous BM-MSCs isolated from IPF patients and age-mathed controls | BM-MSCs from IPF patients have signs of senescence with Mt dysfunction and DNA damage IPF BM-MSCs secreated pro-fibrotic factors and increased illness severity and inflammation in mice |
Mt fragmentation ↓ Mt oxygen consumption and bioenergy ↑ IL-6, IL-8, IL-1β ↑ Pro-fibrotic factors |
Cardenes et al., 2018 [181] | |
Liver | IRI in mice Hepatocites in vitro subjected to H/R injury |
MSCs MSC-CM |
↓ Liver injury Improved liver function ↓ Hepatocellular apoptosis |
↓ ROS in tissue ↑ Parkin/PINK1 mitophagy ↑ ATP production by AMPKα activation |
Zheng et al., 2020 [7] |
IRI in rats Hepatocyte cell culture |
MSC-EVs | ↑ Hepatic recovery ↓ Neutrophil infiltration and respiratory burst ↓ Oxidative stress |
Mt transfer and Mt-located antioxidant enzyme (manganese superoxide dismutase (MnSOD) ↓ ROS—induced hepatocyte apoptosis and cell death in vitro |
Yao et al., 2019 [184] | |
IRI in specimen of human liver grafts (peri-operative) Mouse IRI |
MSC-EVs | Liver graft morphology and function were better preserved Improved liver IRI in mice |
↓ Liver graft inflammation and NET formation ↓ NET formation ↓ Netosis Mt transfer from EVs to intrahepatic neutrophils and their MQ control regulation |
Lu et al., 2022 [185] | |
D-Galactose induced hepatic disorder in rats Mt isolated from liver |
UC-MSCs | Improved liver morphology and function Improved Mt respiration, ΔΨm and ATP production |
↓ Histological lessions and liver enzymes ↑ Mt bioenergy and antioxidant capacity through Nrf2/HO-1 pathway |
Yan et al., 2017 [186] | |
Rat BDL cirrhosis | MSCs, naïve and tranducted with PRL-1 | Liver regeneration Improved liver function Better efficacy of MSC-PRL-1 compared to naïve MSCs |
↑ Metabolic state and Mt biogenesis of MSC-PRL-1 ↑ Engraftment, Mt DNA, biogenesis and ATP production in hepatocytes |
Kim et al., 2020 [187] | |
Rat BDL cirrhosis | MSCs, naïve and tranducted with PRL-1 | ↑ Oxidative capacity of MSC-PRL-1 MSC-PRL-1 vs. naïve MSCs improved further liver function and had greater antifibrotic effect |
↑ Mt biogenesis and Mt lactate of MSC-PRL-1 MSC-PRL-1 have greater antioxidant effect vs. naïve MSCs |
Kim et al., 2023 [188] | |
Mouse NAFLD and diabetes (induced by high fat diet and streptozotocin) Hepatocytes treated with palmitic acid (in vitro) |
MSC-CM | Improvement of insulin resistance and liver morphology ↓ Liver inflammation ↓ Cell apoptosis |
↑ Liver antioxidant capacity ↑ Mt function in liver cells Crucial role of Sirt1 in cell protection |
Yang et al., 2021 [190] | |
Steatohepatitis in mice Hepatocytes and MSC co-culture |
BM-MSCs | ↓ Hepatocyte lipid content of ~40% ↓ Mt and peroxisomal dysfunction |
Donation of Mt to hepatocytes Mt transfer from MSCs to hepatocytes by TNT formation |
Hsu et al., 2020 [192] | |
Steatohepatitis in mice | MSCs | Switch from liver lipid storage to its utilization | Donation of Mt to the hepatocytes Restoration of hepatocyte metabolism and oxidative capacity |
Nickel et al., 2022 [191] | |
Steatohepatitis in mice | MSCs | Improved liver morphology and metabolic function | Improvement of impaired Mt morphology and function ↑ Liver metabolic capacity and host gene shifting |
Newell et al., 2018 [193] | |
MSCs + fibroblasts (from Mt disease patients) −co-culture | MSCs | Improved Mt morphology and function | Inverting abundance of Mt fission toward fussion Mt state | Newell et al., 2018 [193] |
Legend: ↑ increase; ↓ decrease.